Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma

Published:2016-04-26 Issue:5 Volume:22 Page:627-634
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Yanik Elizabeth L.¹,Chinnakotla Srinath²,Gustafson Sally K.³,Snyder Jon J.⁴³,Israni Ajay K.⁴⁵³,Segev Dorry L.³⁶,Engels Eric A.¹

Affiliation:

1. Division of Cancer Epidemiology and Genetics; National Cancer Institute; Rockville MD

2. Department of Surgery, School of Medicine; University of Minnesota; Minneapolis MN

3. Scientific Registry of Transplant Recipients; Minneapolis Medical Research Foundation; Minneapolis MN

4. Department of Epidemiology and Community Health, School of Medicine; University of Minnesota; Minneapolis MN

5. Department of Hennepin County Medical Center, School of Medicine; University of Minnesota; Minneapolis MN

6. School of Medicine; Johns Hopkins University; Baltimore MD

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.24395/fullpdf

Reference28 articles.

1. Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients United States Organ Transplantation: OPTN & SRTR Annual Data Report 2011 2012

2. Review article: the management of hepatocellular carcinoma;Cabrera;Aliment Pharmacol Ther,2010

3. Liver transplantation for hepatocellular carcinoma: five steps to prevent recurrence;Toso;Am J Transplant,2011

4. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation;Schlitt;J Clin Oncol,1999

5. Late recurrence of hepatocellular carcinoma after liver transplantation: is an active surveillance for recurrence needed?;Castroagudín;Transplant Proc,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation;eBioMedicine;2023-06

2. Growing need of adjuvant therapy and expanded access for liver transplant in hepatocellular carcinoma;Annals of Translational Medicine;2023-01

3. Lebendspende Lebertransplantation für erwachsene Empfänger;Organtransplantation mit Lebendspende;2023

4. Leading Approaches to Vascularize Kidney Constructs in Tissue Engineering;Engineering;2022-12

5. mTORi‐based immunosuppression reduces HCC recurrence at the expense of increased adverse side effects: A systematic review and meta‐analysis;Clinical Transplantation;2022-12